Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score

Abstract Background Lung cancer (LC) causes more deaths worldwide than any other cancer type. Despite advances in therapeutic strategies, the fatality rate of LC cases remains high (95%) since the majority of patients are diagnosed at late stages when patient prognosis is poor. Analysis of the Inter...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Karla Rubio, Jason M. Müller, Aditi Mehta, Iris Watermann, Till Olchers, Ina Koch, Sabine Wessels, Marc A. Schneider, Tania Araujo-Ramos, Indrabahadur Singh, Christian Kugler, Mircea Gabriel Stoleriu, Mark Kriegsmann, Martin Eichhorn, Thomas Muley, Olivia M. Merkel, Thomas Braun, Ole Ammerpohl, Martin Reck, Achim Tresch, Guillermo Barreto
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Springer 2023-10-01
Цуврал:	Discover Oncology
Нөхцлүүд:	Lung cancer Biomarker Diagnostic Exhaled breath condensate GATA6 NKX2-1
Онлайн хандалт:	https://doi.org/10.1007/s12672-023-00799-9
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!